Testosterone

Prostate Cancer Risk Reduced in Men with Very Low Free Testosterone

Prostate Cancer Risk Reduced in Men with Very Low Free Testosterone

By

Men in the bottom 10th of free testosterone level vs those with higher levels were found to have a 23% decreased risk of prostate cancer.

Testosterone Prescribing Declining in the US

Testosterone Prescribing Declining in the US

By

From 2013 to 2016, the relative decrease in testosterone prescriptions was 48% among established testosterone users and 62% among new users.

Low Testosterone Linked to Sugar-Sweetened Beverages

Low Testosterone Linked to Sugar-Sweetened Beverages

By

Among men aged 20-39 years, those in the top quartile of sugar-sweetened beverage intake had 2.3-fold greater odds of low testosterone than those in the bottom quartile.

Testosterone Levels May Be Determined in Childhood

Testosterone Levels May Be Determined in Childhood

By

Children who migrated to the UK from Bangladesh before puberty and Bangladeshis born in the UK had significantly higher levels of testosterone compared with life-long residents of Bangladesh.

Testosterone Therapy Safe Despite Prostate Cancer History

Testosterone Therapy Safe Despite Prostate Cancer History

By

Findings from the largest study to date examining the effect of TRT in prostate cancer patients build on previous evidence showing that the treatment does not affect disease progression risk.

Testosterone Therapy Guidelines Updated

Testosterone Therapy Guidelines Updated

By

Screening and treating all healthy men older than 65 years with testosterone is discouraged.

Testosterone Therapy May Lower Prostate Cancer Incidence

Testosterone Therapy May Lower Prostate Cancer Incidence

By

Hypogonadal men who received testosterone replacement therapy had a lower incidence of prostate cancer than those who did not, and their cancers were less severe.

Hypogonadism Ups MetS Risk in Testicular Cancer Patients

Hypogonadism Ups MetS Risk in Testicular Cancer Patients

By

Hypogonadal testicular cancer survivors had 15 times higher odds of metabolic syndrome than their eugonadal counterparts.

2 Percent Daily Testosterone Shows 6-Month Efficacy

2 Percent Daily Testosterone Shows 6-Month Efficacy

Once-daily T-sol administered for 6 months did not indicate new safety concerns, and the outcomes of low sex drive and low energy showed further improvement.

Erectile Dysfunction Predicts Higher Risk of Osteoporosis

Erectile Dysfunction Predicts Higher Risk of Osteoporosis

By

Low testosterone levels may be a contributing factor.

Testosterone Therapy for Severe Hypogonadism Improves Sexual Function

Testosterone Therapy for Severe Hypogonadism Improves Sexual Function

By

The finding is from a 30-week study comparing testosterone undecanoate and placebo in hypogonadal men with type 2 diabetes.

Anabolic Steroids Easily Obtained Without Rx

Anabolic Steroids Easily Obtained Without Rx

By

Alert patients that use of performance-enhancing drugs can lead to erectile dysfunction and infertility.

Novel Oral Testosterone Shows Long-Term Safety, Tolerability

Novel Oral Testosterone Shows Long-Term Safety, Tolerability

By

In particular, no hepatic toxicities emerged during a 52-week phase 3 trial.

Prostate Cancer Risk Not Increased With Testosterone Therapy

Prostate Cancer Risk Not Increased With Testosterone Therapy

By

In fact, some data suggest treatment may reduce prostate cancer incidence and aggressiveness.

TRT Found to Reduce Anemia in Hypogonadal Men

TRT Found to Reduce Anemia in Hypogonadal Men

By

After 54 weeks of treatment with testosterone undecanoate, anemia prevalence decreased from 29.6% to 10%.

Low Testosterone Associated with Higher Death Risk in Male Dialysis Patients

Low Testosterone Associated with Higher Death Risk in Male Dialysis Patients

By

Study also identifies clinical characteristics associated with testosterone deficiency in this population.

Topical Testosterone Restorative for Hypogonadal Men

Topical Testosterone Restorative for Hypogonadal Men

73% of men in the testosterone group showed improvement in sexual arousal, interest, and drive.

Topical Testosterone Restorative for Hypogonadal Men

Topical Testosterone Restorative for Hypogonadal Men

73% of men in the testosterone group showed improvement in sexual arousal, interest, and drive.

Testosterone Modestly Improves Sexual Function in Older Men

Testosterone Modestly Improves Sexual Function in Older Men

Larger studies and long-term follow-up needed to determine possible risks of treatment.

Testosterone Modestly Improves Sexual Function in Older Men

Testosterone Modestly Improves Sexual Function in Older Men

Larger studies and long-term follow-up needed to determine possible risks of treatment.

Cinacalcet for SHPT May Lower Testosterone

Cinacalcet for SHPT May Lower Testosterone

By

Serum total and free testosterone declined in men on hemodialysis who received a 6-month course of the drug for secondary hyperparathyroidism.

Opioid Use Linked to Low Testosterone

Opioid Use Linked to Low Testosterone

Increased odds of low testosterone with opioid exposure; increased odds with increasing age, comorbidities.

Low Testosterone Before ADT Predicts Poor Prognosis in Metastatic PCa

Low Testosterone Before ADT Predicts Poor Prognosis in Metastatic PCa

By

The study found no association with obesity, however, unlike previous studies.

Testosterone Therapy Does Not Appear to Worsen LUTS/BPH

Testosterone Therapy Does Not Appear to Worsen LUTS/BPH

By

A recent review found little evidence to support severe lower urinary tract symptoms as a contraindication to TRT.

Androgen Deprivation Therapy Linked to Alzheimer's Disease

Androgen Deprivation Therapy Linked to Alzheimer's Disease

A new study by University of Pennsylvania and Stanford researchers highlights a possible link between men who receive androgen deprivation therapy (ADT) and the future onset of Alzheimer's disease.

Testosterone Therapy Possibly Increases Insulin Sensitivity

Testosterone Therapy Possibly Increases Insulin Sensitivity

Increased insulin sensitivity in men with type 2 diabetes and hypogonadotropic hypogonadism.

Endocrinologist Groups Reject FDA's Testosterone Therapy Position

Endocrinologist Groups Reject FDA's Testosterone Therapy Position

By

Signs and symptoms and testosterone levels, not the presence of disorders that cause low testosterone, should guide treatment decisions.

Why Heart Safety of Testosterone in Older Men Remains a Concern

Why Heart Safety of Testosterone in Older Men Remains a Concern

Most men prescribed testosterone have age-related hypogonadism, for which treatment is not FDA-approved

Testosterone Therapy Has No Effect on Atherosclerosis Progression

Testosterone Therapy Has No Effect on Atherosclerosis Progression

By

Use of testosterone gel for 3 years did not alter the rate of change in carotid intima-media thickness or coronary artery calcium.

Testosterone Therapy Has No Effect on Atherosclerosis Progression

Testosterone Therapy Has No Effect on Atherosclerosis Progression

By

Use of testosterone gel for 3 years did not alter the rate of change in carotid intima-media thickness or coronary artery calcium.

Sign Up for Free e-newsletters